Loading Purplepass...
R2 Addendum- Changes Impacting Sponsors-CRO-Sites
Presented By Netzealous LLC DBA - Compliance4All
Tuesday, November 6th at 10:00am PST
Online sale ends: 11/06/18 at 9:00am PST
Online
161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA
Fremont, CA 94539
-= series =-
Buy Tickets
|
Talent
Description
Overview: The revised guidelines are entitled "Integrated Addendum To ICH E6(R1): Guideline For Good Clinical Practice E6(R2)." The ICH steering committee comprised of representatives from the pharmaceutical industry and the regulatory bodies of the United States, Japan, the European Union (EU), Canada, and Switzerland. Why should you Attend: In this webinar we will identify the changes impacting investigators, sites, Sponsors, CROs: responsibilities and roles and explain the impact of the revisions on clinical trials conduct and organizational practices. Areas Covered in the Session: GCP E6 R2 Guideline Globalization Risk-based Quality Management (RBQM) SOPs development and implementation, Standardization Who Will Benefit: Directors of Clinical Operations Medical Affairs Specialists and Leaders of this Division Project Managers Grant Administrators Regulatory Affairs Quality Control(QC), Quality Assurance Specialists Speaker Profile: Dr. Malikova has over fourteen years of experience in the clinical research field. She has managed Phase I – IV studies involving investigational drugs, devices and biologics. She has worked on Industry-sponsored and Investigator-initiated trials in the fields of Surgery, Cancer Diagnostics and Interventional Radiology. Event Fee: One Dial-in One Attendee Price: US $150.00 Contact Detail: Compliance4All DBA NetZealous, Phone: +1-800-447-9407 Email: support@compliance4All.com |
Presented By
10:00am to 11:00am
General Admission: $150.00
All Ages
50 18004479407 UPCOMING EVENTS
PAST EVENTS
|
